世界の近視・老眼治療市場2023-2027

◆英語タイトル:Global Myopia and Presbyopia Treatment Market 2023-2027

Technavioが発行した調査報告書(IRTNTR74159-23)◆商品コード:IRTNTR74159-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年9月1日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア、北米、ヨーロッパ、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の近視・老眼治療市場 2023-2027
近視・老眼治療市場は、2022年から2027年の間に7,946.29百万米ドル成長すると予測されており、予測期間中にCAGRは8.09%で加速します。
近視・老眼治療市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長推進要因、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。 この市場は、近視と老眼の有病率の増加、視力ケアに対する意識の高まり、高齢化人口における視力矯正の需要の高まりによって牽引されています。

Technavioの近視・老眼治療市場は以下のように分類されています:

タイプ別:
- 近視治療
- 老眼治療

製品別:
- レンズ・ガラス
- 手術
- 治療薬

地域別:
- アジア
- 北米
- ヨーロッパ
- その他の世界 (ROW)

この研究は、近視・老眼治療の最近の発展が、今後数年間の近視・老眼治療市場の成長を促進する主な理由の1つであることを特定しています。 また、低コストの眼科手術を目的としたメディカルツーリズムの増加や多焦点眼内レンズの登場により、市場での大きな需要が見込まれます。

近視・老眼治療市場に関するレポートは、次の分野をカバーしています:
- 近視・老眼治療の市場規模
- 近視・老眼治療市場予測
- 近視・老眼治療市場の産業分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、このレポートでは、AbbVie Inc., Alcon Inc., Arctic Vision, Bausch Health Companies Inc., BVI Holdings Ltd., Carl Zeiss AG, ENTOD INTERNATIONAL, EssilorLuxottica, F. Hoffmann La Roche Ltd., Johnson and Johnson, Metall Zug AG, NIDEK Co. Ltd., Ophtec BV, Orasis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanjeevan School For Perfect Eyesight, Sydnexis Inc., The Cooper Companies Inc., Topcon Corp., Vision Care Group, Visus Therapeutics Inc., Ziemer Ophthalmic Systems AG, and Evotec SEを含むいくつかの主要な近視・老眼治療市場ベンダーの詳細な分析を提供します。また、近視・老眼治療市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。
当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な産業インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査報告書は、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1.エグゼクティブサマリー
2.市場状況
3.市場規模
4.過去の市場規模
5.ファイブフォース分析
6.近視・老眼治療市場のセグメンテーション:種類別
7.近視・老眼治療市場のセグメンテーション:製品別
8.顧客状況
9.地理的状況
10.推進要因・課題・傾向
11.企業状況
12.企業分析
13.付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global myopia and presbyopia treatment market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global myopia and presbyopia treatment market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Myopia treatment – Market size and forecast 2022-2027
o Exhibit 34: Chart on Myopia treatment – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Myopia treatment – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Myopia treatment – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Myopia treatment – Year-over-year growth 2022-2027 (%)
o 6.4 Presbyopia treatment – Market size and forecast 2022-2027
o Exhibit 38: Chart on Presbyopia treatment – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Presbyopia treatment – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Presbyopia treatment – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Presbyopia treatment – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 44: Chart on Product – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 46: Chart on Comparison by Product
o Exhibit 47: Data Table on Comparison by Product
o 7.3 Lenses and glass – Market size and forecast 2022-2027
o Exhibit 48: Chart on Lenses and glass – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Lenses and glass – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Lenses and glass – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Lenses and glass – Year-over-year growth 2022-2027 (%)
o 7.4 Surgery – Market size and forecast 2022-2027
o Exhibit 52: Chart on Surgery – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Surgery – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Surgery – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Surgery – Year-over-year growth 2022-2027 (%)
o 7.5 Drug – Market size and forecast 2022-2027
o Exhibit 56: Chart on Drug – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Drug – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Drug – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Drug – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 Asia – Market size and forecast 2022-2027
o Exhibit 67: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.4 North America – Market size and forecast 2022-2027
o Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 87: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. – Overview
o Exhibit 112: AbbVie Inc. – Product / Service
o Exhibit 113: AbbVie Inc. – Key news
o Exhibit 114: AbbVie Inc. – Key offerings
o 12.4 Alcon Inc.
o Exhibit 115: Alcon Inc. – Overview
o Exhibit 116: Alcon Inc. – Business segments
o Exhibit 117: Alcon Inc. – Key offerings
o Exhibit 118: Alcon Inc. – Segment focus
o 12.5 Bausch Health Companies Inc.
o Exhibit 119: Bausch Health Companies Inc. – Overview
o Exhibit 120: Bausch Health Companies Inc. – Business segments
o Exhibit 121: Bausch Health Companies Inc. – Key news
o Exhibit 122: Bausch Health Companies Inc. – Key offerings
o Exhibit 123: Bausch Health Companies Inc. – Segment focus
o 12.6 BVI Holdings Ltd.
o Exhibit 124: BVI Holdings Ltd. – Overview
o Exhibit 125: BVI Holdings Ltd. – Product / Service
o Exhibit 126: BVI Holdings Ltd. – Key offerings
o 12.7 Carl Zeiss AG
o Exhibit 127: Carl Zeiss AG – Overview
o Exhibit 128: Carl Zeiss AG – Business segments
o Exhibit 129: Carl Zeiss AG – Key offerings
o Exhibit 130: Carl Zeiss AG – Segment focus
o 12.8 EssilorLuxottica
o Exhibit 131: EssilorLuxottica – Overview
o Exhibit 132: EssilorLuxottica – Business segments
o Exhibit 133: EssilorLuxottica – Key offerings
o Exhibit 134: EssilorLuxottica – Segment focus
o 12.9 Johnson and Johnson
o Exhibit 135: Johnson and Johnson – Overview
o Exhibit 136: Johnson and Johnson – Business segments
o Exhibit 137: Johnson and Johnson – Key news
o Exhibit 138: Johnson and Johnson – Key offerings
o Exhibit 139: Johnson and Johnson – Segment focus
o 12.10 Metall Zug AG
o Exhibit 140: Metall Zug AG – Overview
o Exhibit 141: Metall Zug AG – Business segments
o Exhibit 142: Metall Zug AG – Key offerings
o Exhibit 143: Metall Zug AG – Segment focus
o 12.11 NIDEK Co. Ltd.
o Exhibit 144: NIDEK Co. Ltd. – Overview
o Exhibit 145: NIDEK Co. Ltd. – Business segments
o Exhibit 146: NIDEK Co. Ltd. – Key offerings
o Exhibit 147: NIDEK Co. Ltd. – Segment focus
o 12.12 Ophtec BV
o Exhibit 148: Ophtec BV – Overview
o Exhibit 149: Ophtec BV – Product / Service
o Exhibit 150: Ophtec BV – Key offerings
o 12.13 Orasis Pharmaceuticals Inc.
o Exhibit 151: Orasis Pharmaceuticals Inc. – Overview
o Exhibit 152: Orasis Pharmaceuticals Inc. – Product / Service
o Exhibit 153: Orasis Pharmaceuticals Inc. – Key offerings
o 12.14 Regeneron Pharmaceuticals Inc.
o Exhibit 154: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 155: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 156: Regeneron Pharmaceuticals Inc. – Key offerings
o 12.15 Sydnexis Inc.
o Exhibit 157: Sydnexis Inc. – Overview
o Exhibit 158: Sydnexis Inc. – Product / Service
o Exhibit 159: Sydnexis Inc. – Key offerings
o 12.16 Topcon Corp.
o Exhibit 160: Topcon Corp. – Overview
o Exhibit 161: Topcon Corp. – Business segments
o Exhibit 162: Topcon Corp. – Key news
o Exhibit 163: Topcon Corp. – Key offerings
o Exhibit 164: Topcon Corp. – Segment focus
o 12.17 Ziemer Ophthalmic Systems AG
o Exhibit 165: Ziemer Ophthalmic Systems AG – Overview
o Exhibit 166: Ziemer Ophthalmic Systems AG – Product / Service
o Exhibit 167: Ziemer Ophthalmic Systems AG – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global myopia and presbyopia treatment market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Myopia treatment – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Myopia treatment – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Myopia treatment – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Myopia treatment – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Presbyopia treatment – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Presbyopia treatment – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Presbyopia treatment – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Presbyopia treatment – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Product – Market share 2022-2027 (%)
Exhibits45: Data Table on Product – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on Lenses and glass – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Lenses and glass – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Lenses and glass – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Lenses and glass – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Surgery – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Surgery – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Surgery – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Surgery – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Drug – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Drug – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Drug – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Drug – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. – Overview
Exhibits112: AbbVie Inc. – Product / Service
Exhibits113: AbbVie Inc. – Key news
Exhibits114: AbbVie Inc. – Key offerings
Exhibits115: Alcon Inc. – Overview
Exhibits116: Alcon Inc. – Business segments
Exhibits117: Alcon Inc. – Key offerings
Exhibits118: Alcon Inc. – Segment focus
Exhibits119: Bausch Health Companies Inc. – Overview
Exhibits120: Bausch Health Companies Inc. – Business segments
Exhibits121: Bausch Health Companies Inc. – Key news
Exhibits122: Bausch Health Companies Inc. – Key offerings
Exhibits123: Bausch Health Companies Inc. – Segment focus
Exhibits124: BVI Holdings Ltd. – Overview
Exhibits125: BVI Holdings Ltd. – Product / Service
Exhibits126: BVI Holdings Ltd. – Key offerings
Exhibits127: Carl Zeiss AG – Overview
Exhibits128: Carl Zeiss AG – Business segments
Exhibits129: Carl Zeiss AG – Key offerings
Exhibits130: Carl Zeiss AG – Segment focus
Exhibits131: EssilorLuxottica – Overview
Exhibits132: EssilorLuxottica – Business segments
Exhibits133: EssilorLuxottica – Key offerings
Exhibits134: EssilorLuxottica – Segment focus
Exhibits135: Johnson and Johnson – Overview
Exhibits136: Johnson and Johnson – Business segments
Exhibits137: Johnson and Johnson – Key news
Exhibits138: Johnson and Johnson – Key offerings
Exhibits139: Johnson and Johnson – Segment focus
Exhibits140: Metall Zug AG – Overview
Exhibits141: Metall Zug AG – Business segments
Exhibits142: Metall Zug AG – Key offerings
Exhibits143: Metall Zug AG – Segment focus
Exhibits144: NIDEK Co. Ltd. – Overview
Exhibits145: NIDEK Co. Ltd. – Business segments
Exhibits146: NIDEK Co. Ltd. – Key offerings
Exhibits147: NIDEK Co. Ltd. – Segment focus
Exhibits148: Ophtec BV – Overview
Exhibits149: Ophtec BV – Product / Service
Exhibits150: Ophtec BV – Key offerings
Exhibits151: Orasis Pharmaceuticals Inc. – Overview
Exhibits152: Orasis Pharmaceuticals Inc. – Product / Service
Exhibits153: Orasis Pharmaceuticals Inc. – Key offerings
Exhibits154: Regeneron Pharmaceuticals Inc. – Overview
Exhibits155: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits156: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits157: Sydnexis Inc. – Overview
Exhibits158: Sydnexis Inc. – Product / Service
Exhibits159: Sydnexis Inc. – Key offerings
Exhibits160: Topcon Corp. – Overview
Exhibits161: Topcon Corp. – Business segments
Exhibits162: Topcon Corp. – Key news
Exhibits163: Topcon Corp. – Key offerings
Exhibits164: Topcon Corp. – Segment focus
Exhibits165: Ziemer Ophthalmic Systems AG – Overview
Exhibits166: Ziemer Ophthalmic Systems AG – Product / Service
Exhibits167: Ziemer Ophthalmic Systems AG – Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の近視・老眼治療市場2023-2027(Global Myopia and Presbyopia Treatment Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆